Enhancing Understanding of and Preparedness for Public Health Threats Through Research in Kenya
Centers for Disease Control and Prevention - ERARFA-JG-26-034
Description
This notice of funding opportunity (NOFO) supports research, implementation science, and public health evaluations to inform best practices for preventing and responding to infectious disease threats in Kenya, while strengthening local research capacity.The award recipient will conduct research, implementation science, and public health evaluations through the Kenya Medical Research Institute (KEMRI) and focus on four required priority areas:Influenza and other respiratory pathogens: Activities include surveilling high-risk groups; monitoring for human and avian influenza and other pathogens; and evaluating efficacy and use of vaccines and other treatments. Outcomes include increasing understanding of disease burden and improving vaccination strategies.Vaccine-preventable diseases: Research will assess disease burden, vaccine effectiveness, and sociocultural factors influencing immunization. Outcomes include increasing vaccine uptake and strengthening immunization systems.Drug-resistant infections: Activities include monitoring antimicrobial resistance (AMR) trends, applying novel diagnostics, and identifying drivers of resistance. Outcomes include improving mitigation strategies and global AMR preparedness.Global and emerging health threats: Research will address malaria, HIV, tuberculosis, schistosomiasis, and emerging infections. Outcomes include improving understanding of disease dynamics, intervention effectiveness, and cross-border risks.The recipient will also conduct research coordination and administration activities to manage and oversee U.S. government–funded public health research, ensure compliance with financial and ethical standards, and enhance organizational infrastructure. Outcomes include improved management and compliance with federal funding regulations.The proposed activities under this NOFO will generate evidence to guide U.S. and global preparedness, reduce disease burden and health threats in Kenya, and prevent the spread of health threats across borders.
Award Ceiling
$6.0M
Total Funding
$30.0M
CFDA Number
93.326
Funding Instrument
Cooperative Agreement
Funding Level
Federal
Jurisdiction
US
Cost Sharing
No
Open Date
May 11, 2026
Close Date
June 22, 2026
Posted Date
May 11, 2026
Eligible Applicant Types
Public and State controlled institutions of higher educationFor profit organizations other than small businessesOthers (see text field entitled "Additional Information on Eligibility" for clarification)Small businessesPrivate institutions of higher educationNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Tags
HHS-CDC-HHSCDCERACFDA:93.326Cooperative AgreementHealth
Related Health & Human Services Grants
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
0d left
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
0d left
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
0d left
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
National Institutes of Health
0d left